NCT00077818View on ClinicalTrials.gov

Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2002

Primary Completion Date

February 28, 2005

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Enoxaparin sodium

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00077818 - Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE) | Biotech Hunter | Biotech Hunter